CD19 and B-cell non-Hodgkin lymphoma: Flow cytometric analysis also revealed high levels of CEACAM1 surface expression on MCL PDX models (Fig. 2e) and primary MCL samples (Supplementary Fig. 4a) compared to other B-cell lymphoma or CD19+ naïve B cells.